| Characteristics, consent patterns, and challenges of randomized trials using the Trials within Cohorts (TwiCs) design A scoping review A Amstutz, CM Schönenberger, B Speich, A Griessbach, JM Schwenke, ... Journal of Clinical Epidemiology, 111469, 2024 | | 2024 |
| High certainty evidence is stable and trustworthy, whereas evidence of moderate or lower certainty may be equally prone to being unstable B Djulbegovic, D Koletsi, I Hozo, A Price, ALC Martimbianco, R Riera, ... Journal of clinical epidemiology 171, 111392, 2024 | | 2024 |
| Panel stacking is a threat to consensus statement validity KP Kepp, P Aavitsland, M Ballin, F Balloux, S Baral, K Bardosh, ... Journal of clinical epidemiology, 111428, 2024 | | 2024 |
| Enhancement of STroke REhabilitation with Levodopa (ESTREL): Rationale and design of a randomized placebo-controlled, double blind superiority trial A Zietz, JE Kaufmann, K Wiesner, SK Fischer, M Wiegert, ... European stroke journal, 23969873241255867, 2024 | | 2024 |
| Clinical trial evidence of quality-of-life effects of disease-modifying therapies for multiple sclerosis: a systematic analysis J Hirt, K Dembowska, T Woelfle, C Axfors, C Granziera, J Kuhle, L Kappos, ... Journal of Neurology, 1-11, 2024 | | 2024 |
| Registrering av forskning baserad på nationella hälsoregister C Axfors, O Fröbert, P Janiaud, E Zavalis, LG Hemkens, JPA Ioannidis Lakartidningen 121, 2024 | | 2024 |
| Use of pragmatic randomized trials in multiple sclerosis: A systematic overview J Hirt, P Janiaud, P Düblin, GJ Nicoletti, K Dembowska, TVT Nguyen, ... Multiple Sclerosis Journal 30 (4-5), 463-478, 2024 | 1 | 2024 |
| Methods proposed for monitoring the implementation of evidence-based research: a cross-sectional study L Puljak, MM Bala, J Zając, T Meštrović, S Buttigieg, M Yanakoulia, ... Journal of clinical epidemiology 168, 111247, 2024 | 1 | 2024 |
| Randomised trials conducted using cohorts: a scoping review BJ Nickolls, C Relton, L Hemkens, M Zwarenstein, S Eldridge, SJ McCall, ... BMJ Open 14 (3), e075601, 2024 | 2 | 2024 |
| Effect of dulaglutide in promoting abstinence during smoking cessation: 12-month follow-up of a single-centre, randomised, double-blind, placebo-controlled, parallel group trial H Lüthi, S Lengsfeld, T Burkard, A Meienberg, N Jeanloz, T Vukajlovic, ... Eclinicalmedicine 68, 2024 | 4 | 2024 |
| Benchmarking Human-AI Collaboration for Common Evidence Appraisal Tools T Woelfle, J Hirt, P Janiaud, L Kappos, J Ioannidis, LG Hemkens medRxiv, 2024.04. 21.24306137, 2024 | | 2024 |
| Rationale and design of the Cancer Immunotherapy Evidence Living (CIEL) Library: A continuously updated clinical trial database of cancer immunotherapies K Boesen, J Hirt, P Dueblin, H Laubli, B Kassenda, LG Hemkens, ... medRxiv, 2024.04. 26.24306436, 2024 | | 2024 |
| MultiSCRIPT-Cycle 1-A Pragmatic trial embedded within the Swiss Multiple Sclerosis Cohort (SMSC) on neurofilament light chain monitoring to inform personalized treatment … P Janiaud, C Zecca, A Salmen, P Benkert, S Schaedelin, A Orleth, ... medRxiv, 2024.03. 22.24304720, 2024 | | 2024 |
| Results reporting for clinical trials led by medical universities and university hospitals in the Nordic countries was often missing or delayed G Nilsonne, S Wieschowski, NJ DeVito, M Salholz-Hillel, T Bruckner, ... medRxiv, 2024.02. 04.24301363, 2024 | 3 | 2024 |
| The LYMPH Trial-Comparing Microsurgical with Conservative Treatment of Chronic Breast Cancer Associated Lymphedema: Study Protocol of a Pragmatic Randomized International … EA Kappos, Y Haas, A Schulz, F Peters, S Savanthrapadian, J Stoffel, ... medRxiv, 2024.02. 13.24302744, 2024 | | 2024 |
| Frequency of multiple changes to prespecified primary outcomes of clinical trials completed between 2009 and 2017 in German university medical centers: A meta-research study M Holst, M Haslberger, S Yerunkar, D Strech, LG Hemkens, BG Carlisle Plos Medicine 20 (10), e1004306, 2023 | 2 | 2023 |
| The use of pragmatic randomized trials in Multiple Sclerosis: a systematic overview J Hirt, P Janiaud, P Dublin, GJ Nicoletti, K Dembowska, TVT Nguyen, ... MULTIPLE SCLEROSIS JOURNAL 29, 378-379, 2023 | | 2023 |
| Definitions of digital biomarkers: a systematic mapping of the biomedical literature AKM Alonso, J Hirt, T Woelfle, P Janiaud, LG Hemkens medRxiv, 2023.09. 01.23294897, 2023 | 2 | 2023 |
| Using the phases of clinical development of medicines to describe clinical trials assessing other interventions is widespread but not useful R Dal-Ré, R Banzi, IA Cristea, C Fernández-de-Las-Peñas, LG Hemkens, ... Journal of clinical epidemiology, S0895-4356 (23) 00183-X, 2023 | | 2023 |
| Meta-epidemiological review identified variable reporting and handling of time-to-event analyses in publications of trials included in meta-analyses of systematic reviews M Goldkuhle, C Hirsch, C Iannizzi, AM Bora, R Bender, EC van Dalen, ... Journal of Clinical Epidemiology 159, 174-189, 2023 | | 2023 |
John P.A. IoannidisProfessor of Medicine/Health Research & Policy/Biomedical Data Science/Statistics, Stanford UnivVerified email at stanford.edu